TELA BIO, INC. (TELA): Price and Financial Metrics


TELA BIO, INC. (TELA): $7.36

0.36 (+5.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TELA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TELA Stock Summary

  • TELA has a higher market value than only 21.26% of US stocks; more precisely, its current market capitalization is $169,529,274.
  • TELA Bio Inc's stock had its IPO on November 8, 2019, making it an older stock than merely 6.38% of US equities in our set.
  • As for revenue growth, note that TELA's revenue has grown 61.77% over the past 12 months; that beats the revenue growth of 85.54% of US companies in our set.
  • Stocks that are quantitatively similar to TELA, based on their financial statements, market capitalization, and price volatility, are BSQR, ROG, XERS, PWFL, and SPNE.
  • Visit TELA's SEC page to see the company's official filings. To visit the company's web site, go to www.telabio.com.

TELA Valuation Summary

  • TELA's price/earnings ratio is -5.9; this is 116.16% lower than that of the median Healthcare stock.
  • Over the past 22 months, TELA's EV/EBIT ratio has gone up 2.3.
  • Over the past 22 months, TELA's price/sales ratio has gone down 9.4.

Below are key valuation metrics over time for TELA.

Stock Date P/S P/B P/E EV/EBIT
TELA 2021-08-31 7.8 5.4 -5.9 -5.7
TELA 2021-08-30 8.0 5.6 -6.1 -5.8
TELA 2021-08-27 7.9 5.5 -6.1 -5.8
TELA 2021-08-26 8.2 5.7 -6.2 -6.0
TELA 2021-08-25 8.2 5.7 -6.2 -6.0
TELA 2021-08-24 8.2 5.7 -6.3 -6.0

TELA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TELA has a Quality Grade of C, ranking ahead of 27.58% of graded US stocks.
  • TELA's asset turnover comes in at 0.295 -- ranking 132nd of 183 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows TELA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.295 0.635 -0.825
2021-03-31 0.230 0.614 -0.754
2020-12-31 0.217 0.617 -0.700
2020-09-30 0.220 0.605 -0.624
2020-06-30 0.260 0.613 -0.546
2019-12-31 0.325 0.600 -0.536

TELA Price Target

For more insight on analysts targets of TELA, see our TELA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.00 Average Broker Recommendation 1.25 (Strong Buy)

TELA Stock Price Chart Interactive Chart >

Price chart for TELA

TELA Price/Volume Stats

Current price $7.36 52-week high $16.53
Prev. close $7.00 52-week low $6.32
Day low $6.96 Volume 48,600
Day high $7.55 Avg. volume 34,877
50-day MA $9.87 Dividend yield N/A
200-day MA $11.92 Market Cap 107.15M

TELA BIO, INC. (TELA) Company Bio


TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.


TELA Latest News Stream


Event/Time News Detail
Loading, please wait...

TELA Latest Social Stream


Loading social stream, please wait...

View Full TELA Social Stream

Latest TELA News From Around the Web

Below are the latest news stories about TELA Bio Inc that investors may wish to consider to help them evaluate TELA as an investment opportunity.

TELA Bio - Follow Up With Management

No summary available.

Seeking Alpha | January 14, 2022

Reviewing Biostage (OTCMKTS:BSTG) & TELA Bio (NASDAQ:TELA)

Biostage (OTCMKTS:BSTG) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Insider and Institutional Ownership 0.3% of Biostage shares are owned by institutional investors. Comparatively, 83.3% of [] The post Reviewing Biostage (OTCMKTS:BSTG) & TELA Bio (NASDAQ:TELA) appeared first on ETF Daily News .

ETF Daily News | December 23, 2021

Head-To-Head Contrast: TELA Bio (NASDAQ:TELA) vs. Beyond Air (NASDAQ:XAIR)

TELA Bio (NASDAQ:TELA) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Profitability This table compares TELA Bio and Beyond Airs net margins, return on equity and []

Transcript Daily | December 18, 2021

Head-To-Head Comparison: Biostage (OTCMKTS:BSTG) & TELA Bio (NASDAQ:TELA)

TELA Bio (NASDAQ:TELA) and Biostage (OTCMKTS:BSTG) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Risk & Volatility TELA Bio has a beta of 1.66, suggesting that its share price is []

Dakota Financial News | December 18, 2021

TELA Bio, Inc. (NASDAQ:TELA) Insider Ew Healthcare Partners Fund 2, Buys 1,387 Shares

TELA Bio, Inc. (NASDAQ:TELA) insider Ew Healthcare Partners Fund 2, bought 1,387 shares of the companys stock in a transaction on Friday, December 10th. The stock was bought at an average price of $12.49 per share, for a total transaction of $17,323.63. The acquisition was disclosed in a legal filing with the Securities & Exchange []

Dakota Financial News | December 14, 2021

Read More 'TELA' Stories Here

TELA Price Returns

1-mo -20.16%
3-mo -40.40%
6-mo -41.21%
1-year -46.43%
3-year N/A
5-year N/A
YTD -42.50%
2021 -14.89%
2020 16.14%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7398 seconds.